Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin add-on to Escitalopram in Patients With Comorbid Obesity and Major Depression
DRKS00021119Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD), persistent depressive disorder (PDD) and obesity comparing Escitalopram + Simvastatin with Escitalopram + Placebo (2 arms). Started Mar 2020; status: completed.
02
Drugs
simvastatin
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)obesity
Beyond the preview
Go deeper on DRKS00021119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00021119.